# Drug-drug Interaction Study of FYU-981 and Oxaprozin

> **NCT03350386** · PHASE1 · COMPLETED · sponsor: **Mochida Pharmaceutical Company, Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** FYU-981
- **DRUG:** Oxaprozin

## Key facts

- **NCT ID:** NCT03350386
- **Lead sponsor:** Mochida Pharmaceutical Company, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-02
- **Primary completion:** 2017-12-05
- **Final completion:** 2017-12-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350386, "Drug-drug Interaction Study of FYU-981 and Oxaprozin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03350386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*